Login / Signup

Bayesian transition models for ordinal longitudinal outcomes.

Maximilian D RohdeBenjamin FrenchThomas G StewartFrank E Harrell
Published in: Statistics in medicine (2024)
Ordinal longitudinal outcomes are becoming common in clinical research, particularly in the context of COVID-19 clinical trials. These outcomes are information-rich and can increase the statistical efficiency of a study when analyzed in a principled manner. We present Bayesian ordinal transition models as a flexible modeling framework to analyze ordinal longitudinal outcomes. We develop the theory from first principles and provide an application using data from the Adaptive COVID-19 Treatment Trial (ACTT-1) with code examples in R. We advocate that researchers use ordinal transition models to analyze ordinal longitudinal outcomes when appropriate alongside standard methods such as time-to-event modeling.
Keyphrases
  • clinical trial
  • coronavirus disease
  • sars cov
  • cross sectional
  • metabolic syndrome
  • study protocol
  • glycemic control
  • insulin resistance
  • open label
  • phase ii
  • weight loss
  • artificial intelligence
  • health information